These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11149208)

  • 1. [Syncope after administration of moxifloxacin].
    Carrión Valero F; Fácila Rubio L; Marín Pardo J
    Arch Bronconeumol; 2000 Nov; 36(10):603-4. PubMed ID: 11149208
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypertensive crisis and transitory left brunch block with QT interval prolongation associated to moxifloxacin].
    Salvador García Morillo J; Stiefel García-Junco P; Vallejo Maroto I; Carneado de la Fuente J
    Med Clin (Barc); 2001 Jul; 117(5):198-9. PubMed ID: 11481090
    [No Abstract]   [Full Text] [Related]  

  • 3. Reassuring safety profile of moxifloxacin.
    Iannini PB; Kubin R; Reiter C; Tillotson G
    Clin Infect Dis; 2001 Apr; 32(7):1112-4. PubMed ID: 11264046
    [No Abstract]   [Full Text] [Related]  

  • 4. Moxifloxacin-induced acute liver injury.
    Soto S; López-Rosés L; Avila S; Lancho A; González A; Santos E; Urraca B
    Am J Gastroenterol; 2002 Jul; 97(7):1853-4. PubMed ID: 12135060
    [No Abstract]   [Full Text] [Related]  

  • 5. Simultaneous drug allergies.
    González-Mancebo E; Cuevas M; González González E; Lara Cátedra C; Dolores Alonso M
    Allergy; 2002 Oct; 57(10):963-4. PubMed ID: 12269953
    [No Abstract]   [Full Text] [Related]  

  • 6. Beau's lines in a patient treated with moxifloxacin for anaerobic pulmonary infection.
    Burkhardt O; Allewelt M; Pletz MW; Welte T; Lode H
    Scand J Infect Dis; 2003; 35(8):516-8. PubMed ID: 14514159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An updated safety profile of moxifloxacin.
    Iannini PB; Mandell LA
    J Chemother; 2002 Feb; 14 Suppl 2():29-34. PubMed ID: 12003138
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug Points: tachycardia associated with moxifloxacin.
    Siepmann M; Kirch W
    BMJ; 2001 Jan; 322(7277):23. PubMed ID: 11141146
    [No Abstract]   [Full Text] [Related]  

  • 9. Anaphylactoid reaction caused by moxifloxacin.
    Alemán AM; Quirce S; Cuesta J; Novalbos A; Sastre J
    J Investig Allergol Clin Immunol; 2002; 12(1):67-8. PubMed ID: 12109537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moxifloxacin does increase the corrected QT interval.
    White CM; Grant EM; Quintiliani R
    Clin Infect Dis; 2001 Oct; 33(8):1441-4. PubMed ID: 11565091
    [No Abstract]   [Full Text] [Related]  

  • 11. Preclinical safety evaluation of moxifloxacin, a novel fluoroquinolone.
    von Keutz E; Schlüter G
    J Antimicrob Chemother; 1999 May; 43 Suppl B():91-100. PubMed ID: 10382881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Torsade de pointes associated with moxifloxacin: a rare but potentially fatal adverse event.
    Altin T; Ozcan O; Turhan S; Ongun Ozdemir A; Akyurek O; Karaoguz R; Guldal M
    Can J Cardiol; 2007 Sep; 23(11):907-8. PubMed ID: 17876386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moxifloxacin-induced Clostridium difficile diarrhea.
    Ortiz-de-Saracho J; Pantoja L; Romero MJ; López R
    Ann Pharmacother; 2003 Mar; 37(3):452-3. PubMed ID: 12639182
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluoroquinolone phototoxicity: a comparison of moxifloxacin and lomefloxacin in normal volunteers.
    Man I; Murphy J; Ferguson J
    J Antimicrob Chemother; 1999 May; 43 Suppl B():77-82. PubMed ID: 10382879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent tendinitis after treatment with two different fluoroquinolones.
    Burkhardt O; Köhnlein T; Pap T; Welte T
    Scand J Infect Dis; 2004; 36(4):315-6. PubMed ID: 15198194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical perspectives on new antimicrobials: focus on fluoroquinolones.
    Talan DA
    Clin Infect Dis; 2001 Mar; 32 Suppl 1():S64-71. PubMed ID: 11249831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Moxifloxacin: results of clinical use].
    Iakovlev VP; Polushkina NR
    Antibiot Khimioter; 2002; 47(10):32-6. PubMed ID: 12674792
    [No Abstract]   [Full Text] [Related]  

  • 18. Status epilepticus attributed to moxifloxacin in an adolescent patient with spina bifida occulta.
    Qiao L; Cui X; Li Y
    Eur J Clin Pharmacol; 2011 Jan; 67(1):103-4. PubMed ID: 20809082
    [No Abstract]   [Full Text] [Related]  

  • 19. [Moxifloxacin--a novel antimicrobial preparation for treatment of respiratory infections].
    Iakovlev SV; Polushkina NR; Iakovlev VP
    Ter Arkh; 2001; 73(11):15-22. PubMed ID: 11806197
    [No Abstract]   [Full Text] [Related]  

  • 20. Moxifloxacin Bayer.
    Barrett JF
    Curr Opin Investig Drugs; 2000 Sep; 1(1):45-51. PubMed ID: 11249594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.